Medical Injection Moulding Validation From IQ OQ PQ to Production for OEMs
A medical plastic part can look correct after a tool trial and still be far from ready for validated production. The gap is not cosmetic. It is the difference between proving that a mould can make parts and proving that a controlled process can repeatedly make conforming parts.
For medical device OEMs and startups, this distinction matters early. A missed tolerance, an unstable snap-fit, flash near a sealing area, or inconsistent cavity output can lead to repeated trials, delayed sampling, and difficult design changes later.
This article explains medical injection moulding validation in practical terms, with a focus on IQ, OQ, PQ, critical quality attributes, sampling rationale, process windows, cavity variation, and revalidation. It is written for teams planning plastic medical device components in India and working with design, tooling, and moulding partners.
Tool trials and validation are not the same activity
A tool trial answers useful but limited questions.
Can the mould fill?
Are there short shots, burns, sink marks, flash, weld lines, or ejection marks?
Are the gates, vents, cooling, and ejection working as intended?
Do the early parts suggest that the design and mould are moving in the right direction?
These are important questions. Tool trials help improve the mould and process. They also support DFM feedback, dimensional review, assembly checks, and decisions on tool corrections.
But a tool trial is not validated production.
Validated production needs documented evidence that a defined process, using defined inputs and controls, can repeatedly produce parts that meet defined requirements. That evidence normally includes a planned approach to IQ OQ PQ, process validation, measurement methods, sampling rationale, acceptance criteria, and change control.
A useful way to separate the two is this:
Tool trial | Validated production |
Finds and fixes moulding issues | Confirms repeatable production capability |
May use changing settings | Uses approved process parameters |
Often supports design and tool correction | Supports release to controlled manufacture |
Inspection may be exploratory | Inspection follows an approved plan |
Output may not be saleable or releasable | Output can be considered under the approved quality plan |
A trial can produce good parts. That does not make it validation. Validation requires planning, evidence, and control.
What IQ, OQ, and PQ mean in injection moulding
IQ, OQ, and PQ are common terms in medical device manufacturing. The exact content should match the product risk, process complexity, quality system, and regulatory expectations. The concepts are widely used, but the details should be justified for each project.
IQ confirms that the setup is installed and ready
Installation Qualification, or IQ, checks that the required mould, machine, utilities, auxiliary equipment, gauges, instructions, and documents are in place and suitable for use.
For injection moulding, IQ may address items such as:
Correct mould identification and revision
Machine and auxiliary equipment identification
Material handling and drying arrangements, where applicable
Tooling, inserts, jigs, fixtures, and inspection gauges
Calibration status of measuring instruments
Approved drawings, specifications, work instructions, and inspection plans
Operator instructions and setup records
Preventive maintenance or tool maintenance requirements
IQ does not prove the part is good. It proves the production setup is defined and ready to be challenged.
OQ challenges the process window
Operational Qualification, or OQ, studies whether the process can produce acceptable output across selected operating conditions.
This is where the team explores and justifies the process window. In injection moulding, relevant parameters may include melt temperature, mould temperature, injection speed, holding pressure, holding time, cooling time, screw recovery, cushion, drying conditions, and other settings linked to part quality.
The aim is not to test every possible setting. The aim is to identify which parameters matter, challenge them in a controlled way, and understand how they affect critical features.
For example, holding pressure may influence sink, weight, dimensions, or sealing surfaces. Cooling time may influence shrinkage, warpage, or safe ejection. Injection speed may influence short shot risk, burn marks, weld line strength, or cosmetic defects.
OQ should be based on risk and product knowledge. A simple non-critical cover part does not need the same study depth as a tight-tolerance component used in a fluid path or a functional assembly.
PQ confirms repeatability under normal production conditions
Performance Qualification, or PQ, checks that the approved process works in normal production conditions over defined runs, shifts, operators, cavities, lots, or other planned conditions.
PQ is closer to real production than OQ. It should use the approved process window or nominal settings, normal materials, current documents, trained operators, and standard inspection methods.
PQ looks for repeatability. It asks:
Can the process keep producing acceptable parts?
Do all cavities remain within requirements?
Do dimensions drift over time?
Are start-up and steady-state parts controlled?
Are assemblies, jigs, and inspection methods working as intended?
Are defects found and handled through the defined process?
PQ is not a one-part inspection event. It is evidence that normal production can remain under control.
Critical quality attributes must lead the validation plan
Validation should start with the product requirements, not with a fixed sample count copied from another project.
A critical quality attribute, often called a CQA, is a feature or property that affects safety, performance, assembly, usability, or downstream processing. In medical injection moulding, CQAs may include:
Dimensions that affect fit, locking, or sealing
Wall thickness in functional areas
Part weight where it indicates fill consistency
Flash near patient-contact, sealing, or assembly areas
Burrs, sharp edges, or particulate risk
Warpage that affects assembly or function
Gate vestige height
Surface finish where it affects mating, movement, or cleaning
Insert position in insert moulded parts
Visual defects that affect function or acceptance
Pull force, leak performance, snap-fit force, or other functional tests
Not every dimension on a drawing has the same risk. A good validation plan identifies the important features and links them to process inputs and inspection methods.
This is where design for manufacturability matters. If a drawing has tight tolerances in areas affected by shrinkage, steel-safe changes, parting line mismatch, or cavity balance, the team should discuss these during DFM and tool design. Late discovery during PQ is expensive and avoidable.
Medimals Healthcare, Chennai supports medical device teams in areas such as product design, DFM, jigs, mould design, mould making, and injection moulding. These capabilities can support the journey from early development to controlled moulding. The specific validation strategy, acceptance criteria, and regulatory submission approach should still be defined by the OEM according to the product, market, risk class, and applicable quality system.
Sampling should be justified, not copied
There is no universal sample count that suits every medical injection moulded part. There is also no universal acceptance limit that can be applied across all devices, materials, moulds, and risks.
Sampling should be justified based on factors such as:
Product risk and intended use
Number of cavities
Criticality of dimensions and functions
Expected process variation
Measurement system capability
Material behaviour and shrinkage
Historical knowledge from similar parts, where available
Mould complexity and tool maturity
Whether the feature is visual, dimensional, functional, or destructive to test
Applicable internal procedures and regulatory expectations
A one-cavity development mould, an eight-cavity production mould, and a family mould may need different sampling logic. A part with a simple clearance fit is different from a part with a sealing surface or snap feature.
Good sampling plans also say where samples come from. Taking many parts from one short stretch of steady production may not reveal start-up variation, cavity variation, drift, or material-related behaviour.
Sampling may need to cover:
Start, middle, and end of a run
Each cavity separately
Different machine conditions within the approved window
Multiple material lots, if justified
Different operators or shifts, if relevant
Functional assemblies, where part performance depends on fit
Inspection supports validation, but it is not the same as validation. Inspection checks whether selected parts meet requirements. Validation checks whether the process, under defined controls, can keep producing parts that meet requirements.
Cavity variation needs its own attention
Multi-cavity moulds can improve output, but they add another validation challenge. Cavities may not behave exactly the same. Small differences in flow length, venting, cooling, steel dimensions, gate balance, or ejection can show up as dimensional or visual variation.
If samples from all cavities are mixed together, the average may look acceptable while one cavity is drifting close to a limit. That is why cavity identification is important during trials and validation.
Cavity-level review can help answer practical questions:
Does one cavity show more flash?
Does one cavity run heavier or lighter?
Are dimensions different between cavities?
Is there a cavity-specific issue with gate vestige, sink, or ejection mark?
Does one cavity fail more often in assembly or functional checks?
Cavity variation does not always mean the tool is bad. Some variation is expected. The question is whether the variation is understood, controlled, and acceptable against the product requirements.
For medical moulding, cavity traceability during validation is a strong practice. It helps the team decide whether to correct steel, adjust process settings, improve venting, review cooling, or modify inspection controls.
Process windows should be realistic for production
A process window is the approved range within which the process can run and still produce conforming parts. It should not be so narrow that normal production cannot maintain it. It should not be so wide that quality depends on luck.
A useful process window balances three needs:
Part quality
The selected settings must make parts that meet dimensional, visual, and functional requirements.
Process stability
The process should tolerate normal production variation such as minor temperature drift, normal material variation, and routine start-up conditions.
Manufacturing practicality
The cycle time, ejection, handling, inspection, and assembly flow should be realistic for production.
The window should be built from evidence. OQ helps define the limits. PQ confirms that the chosen settings work in production-like conditions.
For example, if the upper end of holding pressure gives acceptable dimensions but causes flash, and the lower end avoids flash but causes sink, the actual usable range may be smaller than expected. That learning should be documented and reflected in approved settings, control plans, and operator instructions.
Start-up controls are also part of the picture. The first parts after machine start, stoppage, material change, or tool intervention may behave differently. A validation plan should define how start-up parts are handled and when production output is considered stable.
Revalidation is part of lifecycle control
Validation is not a one-time file that gets archived and forgotten. Injection moulding processes can change over time. Revalidation, or at least a documented assessment, may be needed when changes could affect product quality.
Common triggers include:
Tool repair, refurbishment, or modification
Cavity correction or replacement
Change in moulding machine
Change in material grade, supplier, or colourant
Change in process parameters outside the approved window
Change in auxiliary equipment, drying method, or cooling arrangement
Change in inspection method, gauge, or test fixture
Change in product design or drawing revision
Repeated nonconformance or unexplained process drift
Transfer of production to another site or setup
Not every change requires full IQ, OQ, and PQ again. The response should match the risk and impact. A minor documented adjustment may need engineering review and limited verification. A major tool or material change may need broader revalidation.
The key is to avoid undocumented changes. If the approved process is changed without assessment, the earlier validation evidence may no longer apply.
A practical validation checklist for OEMs and startups
Use this checklist as a planning aid. It is not a replacement for a formal quality procedure or regulatory advice.
Define the part requirements clearly Confirm drawings, material, critical dimensions, visual criteria, functional requirements, and assembly needs.
Complete DFM before tool commitment Review wall thickness, draft, ribs, gates, parting line, shrinkage, undercuts, tolerance risks, and inspection access.
Plan tool trials separately from validation Use trials to improve the mould and process before starting formal validation evidence.
Identify critical quality attributes Link CQAs to safety, function, assembly, usability, and downstream processing.
Confirm measurement methods Use suitable gauges, fixtures, visual standards, and test methods before relying on inspection data.
Keep cavity identity visible Mark or segregate samples by cavity during trials, OQ, and PQ.
Justify sampling plans Base sample selection on risk, cavity count, process knowledge, test type, and applicable procedures.
Challenge the process window Study the process settings that can affect quality. Document the approved range.
Separate inspection from validation Inspection gives data. Validation uses planned evidence to show process repeatability.
Define change and revalidation rules Decide what changes need review, verification, partial revalidation, or full revalidation.
FAQs on medical injection moulding validation
Is a successful tool trial enough to start medical device production?
No. A successful tool trial shows that the mould and process are moving in the right direction. Validated production needs documented evidence that the approved setup and process can repeatedly make conforming parts under defined controls.
How many samples are needed for IQ, OQ, and PQ?
There is no universal sample count. Sampling should be justified based on product risk, cavity count, critical features, test method, expected variation, and the applicable quality procedure. Fixed numbers copied from another project can give false confidence.
Who should define the acceptance limits for validation?
Acceptance limits should come from approved product requirements, drawings, specifications, functional needs, risk analysis, and applicable standards or procedures. The moulding partner can support manufacturability and process evidence, but the OEM should own the product requirements and release decisions.
Move from trial parts to controlled production with the right support
Medical injection moulding validation works best when design, tooling, moulding, inspection, and quality planning are connected from the start. Early DFM can reduce mould corrections. Good cavity-wise data can reveal issues before production release. A clear IQ, OQ, and PQ plan can prevent confusion between good trial samples and a controlled process.
Medimals Healthcare, Chennai supports OEMs and startups with product design, DFM, jigs, mould design, mould making, and injection moulding for medical device components. For project discussions, visit Medimals Healthcare and start with the part requirements, intended use, and expected production route.
Validation is strongest when it is practical, documented, and linked to real product risk. Build the evidence before production pressure begins.
Comments